StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.21BP/E –Yield –

OPKO Health cash

Cash and short-term investments held at the end of each period.

OPKO Health's cash was $300.76M at Jun 30, 2026. For fiscal 2025 it was $364.41M, down 14.6% from the year before. Over ten years it grew 6.5% a year on average. The highest annual figure on record is $426.58M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$364.41M-14.6%
FY2024Dec 31, 2024$426.58M+344.9%
FY2023Dec 31, 2023$95.88M-37.4%
FY2022Dec 31, 2022$153.19M+13.7%
FY2021Dec 31, 2021$134.71M+86.6%
FY2020Dec 31, 2020$72.21M-15.5%
FY2019Dec 31, 2019$85.45M-11.4%
FY2018Dec 31, 2018$96.47M+5.4%
FY2017Dec 31, 2017$91.50M-45.8%
FY2016Dec 31, 2016$168.73M-12.8%
FY2015Dec 31, 2015$193.60M+99.8%
FY2014Dec 31, 2014$96.91M-47.8%
FY2013Dec 31, 2013$185.80M+579.1%
FY2012Dec 31, 2012$27.36M-61.7%
FY2011Dec 31, 2011$71.52M+297.0%
FY2010Dec 31, 2010$18.02M-57.8%
FY2009Dec 31, 2009$42.66M+538.8%
FY2008Dec 31, 2008$6.68M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$300.76M+12.5%
Q1 FY2026Mar 31, 2026$331.86M-22.6%
Q4 FY2025Dec 31, 2025$364.41M-14.6%
Q3 FY2025Sep 30, 2025$411.97M+3.0%
Q2 FY2025Jun 30, 2025$267.28M+558.7%
Q1 FY2025Mar 31, 2025$428.83M+466.9%
Q4 FY2024Dec 31, 2024$426.58M+344.9%
Q3 FY2024Sep 30, 2024$400.08M+188.6%
Q2 FY2024Jun 30, 2024$40.58M-62.5%
Q1 FY2024Mar 31, 2024$75.64M-31.8%
Q4 FY2023Dec 31, 2023$95.88M-37.4%
Q3 FY2023Sep 30, 2023$138.62M-23.3%
Q2 FY2023Jun 30, 2023$108.11M-48.6%
Q1 FY2023Mar 31, 2023$110.83M+8.4%
Q4 FY2022Dec 31, 2022$153.19M+13.7%
Q3 FY2022Sep 30, 2022$180.84M+21.7%
Q2 FY2022Jun 30, 2022$210.46M+220.1%
Q1 FY2022Mar 31, 2022$102.28M+14.3%
Q4 FY2021Dec 31, 2021$134.71M+86.6%
Q3 FY2021Sep 30, 2021$148.60M+309.4%
Q2 FY2021Jun 30, 2021$65.76M+204.3%
Q1 FY2021Mar 31, 2021$89.50M+159.2%
Q4 FY2020Dec 31, 2020$72.21M-15.5%
Q3 FY2020Sep 30, 2020$36.29M-43.9%
Q2 FY2020Jun 30, 2020$21.61M-80.5%
Q1 FY2020Mar 31, 2020$34.53M-83.3%
Q4 FY2019Dec 31, 2019$85.45M-11.4%
Q3 FY2019Sep 30, 2019$64.67M+47.9%
Q2 FY2019Jun 30, 2019$111.12M+38.2%
Q1 FY2019Mar 31, 2019$207.25M+107.4%
Q4 FY2018Dec 31, 2018$96.47M+5.4%
Q3 FY2018Sep 30, 2018$43.72M-56.4%
Q2 FY2018Jun 30, 2018$80.38M-38.4%
Q1 FY2018Mar 31, 2018$99.94M-23.7%
Q4 FY2017Dec 31, 2017$91.50M-45.8%
Q3 FY2017Sep 30, 2017$100.36M-30.6%
Q2 FY2017Jun 30, 2017$130.53M–
Q1 FY2017Mar 31, 2017$131.05M–
Q4 FY2016Dec 31, 2016$168.73M–
Q3 FY2016Sep 30, 2016$144.65M–

More OPKO Health figures

See a number that looks wrong?